Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NVRO

Nevro (NVRO) Stock Price, News & Analysis

Nevro logo

About Nevro Stock (NYSE:NVRO)

Key Stats

Today's Range
$5.84
$5.86
50-Day Range
$5.85
$5.85
52-Week Range
$3.17
$10.34
Volume
753,602 shs
Average Volume
818,428 shs
Market Capitalization
$224.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.36
Consensus Rating
Hold

Company Overview

Receive NVRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nevro and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVRO Stock News Headlines

Front-Run Buffett's Shocking Gold Move
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.tc pixel
See More Headlines

NVRO Stock Analysis - Frequently Asked Questions

Nevro Corp. (NYSE:NVRO) issued its quarterly earnings data on Tuesday, March, 4th. The medical equipment provider reported ($0.64) earnings per share for the quarter, beating analysts' consensus estimates of ($0.79) by $0.15. The medical equipment provider had revenue of $105.55 million for the quarter, compared to analysts' expectations of $102.61 million. Nevro had a negative net margin of 16.54% and a negative trailing twelve-month return on equity of 23.52%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nevro investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
3/04/2025
Today
10/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NVRO
CIK
1444380
Fax
N/A
Employees
1,090
Year Founded
2006

Price Target and Rating

High Price Target
$7.00
Low Price Target
$4.00
Potential Upside/Downside
-8.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$92.21 million
Net Margins
-16.54%
Pretax Margin
-17.89%
Return on Equity
-23.52%
Return on Assets
-10.83%

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
5.02
Quick Ratio
3.76

Sales & Book Value

Annual Sales
$408.52 million
Price / Sales
0.55
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.10 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
38,372,000
Free Float
36,273,000
Market Cap
$224.32 million
Optionable
Optionable
Beta
0.81

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:NVRO) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners